When human umbilical cord MSCs and gastric cancer cells merge in vitro, tumorigenic hybrids are created that demonstrate increased expression of stemness markers, such as CD44, CD133, OCT4, SOX2, and NANOG (316). This evidence concerns the gene NANOG and gastric cancer.